Paper42298613
Construction of PANoptosis-related lncRNA prognostic model and immunotherapy sensitivity analysis in lung adenocarcinoma.
Xiong X and 2 others. J Cardiothorac Surg, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Construction of PANoptosis-related lncRNA prognostic model and immunotherapy sensitivity analysis in lung adenocarcinoma. Papers, record 42298613. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42298613
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Construction of PANoptosis-related lncRNA prognostic model and immunotherapy sensitivity analysis in lung adenocarcinoma.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| RNA, Long Noncoding | Major topic |
| Lung Neoplasms | Major topic |
| Adenocarcinoma of Lung | Major topic |
| Immunotherapy | Major topic |
| Humans | |
| Prognosis | |
| Female | |
| Male | |
| Biomarkers, Tumor | |
| Middle Aged |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 202311525 | Science and Technology Plan of Jiangxi Provincial Health Commission | PubMed |
Source PubMed
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35164653 | Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression. | Bioengineered | 2022 | https://conductscience.org/library/papers/35164653 | PubMed |
| 2 | 34174817 | LABRAT reveals association of alternative polyadenylation with transcript localization, RNA binding protein expression, transcription speed, and cancer survival. | BMC Genomics | 2021 | https://conductscience.org/library/papers/34174817 | PubMed |
| 3 | 36216888 | Drugging p53 in cancer: one protein, many targets. | Nat Rev Drug Discov | 2023 | https://conductscience.org/library/papers/36216888 | PubMed |
| 4 | 37822882 | A disulfidptosis-related lncRNA prognostic model to predict survival and response to immunotherapy in lung adenocarcinoma. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37822882 | PubMed |
| 5 | 38069556 | PANoptosis in cancer, the triangle of cell death. | Cancer Med | 2023 | https://conductscience.org/library/papers/38069556 | PubMed |
| 6 | 32582562 | The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis). | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/32582562 | PubMed |
| 7 | 37936698 | Pembrolizumab combined with anlotinib improves therapeutic efficacy in pulmonary sarcomatoid carcinoma with TMB-H and PD-L1 expression: a case report and literature review. | Front Immunol | 2023 | https://conductscience.org/library/papers/37936698 | PubMed |
| 8 | 35002507 | LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma. | Int J Biol Sci | 2022 | https://conductscience.org/library/papers/35002507 | PubMed |
| 9 | 35736637 | LINC00892 Is an lncRNA Induced by T Cell Activation and Expressed by Follicular Lymphoma-Resident T Helper Cells. | Noncoding RNA | 2022 | https://conductscience.org/library/papers/35736637 | PubMed |
| 10 | 38008741 | Exploiting innate immunity for cancer immunotherapy. | Mol Cancer | 2023 | https://conductscience.org/library/papers/38008741 | PubMed |
| 11 | 33958760 | LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy. | Nat Cell Biol | 2021 | https://conductscience.org/library/papers/33958760 | PubMed |
| 12 | 37267949 | NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs. | Cell | 2023 | https://conductscience.org/library/papers/37267949 | PubMed |
| 13 | 36050740 | Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma. | World J Surg Oncol | 2022 | https://conductscience.org/library/papers/36050740 | PubMed |
| 14 | 33494181 | Immune Resistance in Lung Adenocarcinoma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33494181 | PubMed |
| 15 | 33931925 | Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancer. | Cancer Sci | 2021 | https://conductscience.org/library/papers/33931925 | PubMed |
| 16 | 34471287 | AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. | Nature | 2021 | https://conductscience.org/library/papers/34471287 | PubMed |
| 17 | 37948864 | Ursodeoxycholic acid alleviates sepsis-induced lung injury by blocking PANoptosis via STING pathway. | Int Immunopharmacol | 2023 | https://conductscience.org/library/papers/37948864 | PubMed |
| 18 | 33732373 | FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma. | Oncol Lett | 2021 | https://conductscience.org/library/papers/33732373 | PubMed |
| 19 | 26712084 | Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. | Lancet | 2016 | https://conductscience.org/library/papers/26712084 | PubMed |
| 20 | 35192052 | TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/35192052 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42298613
GET https://conductscience.org/api/papers/v1/42298613/references?page=2